Use of Levosimendan as a Strategy to Wean Off Veno-Arterial ECMO in Cardiogenic Shock; A Systematic Review and Metanalysis

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.487
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

When Traditional Research Fails - The Case for Veno-Arterial ECMO in Postcardiotomy Cardiogenic Shock

Anaesthesia
AnesthesiologyPain Medicine
2017English

Postcardiotomy VA-ECMO for Refractory Cardiogenic Shock

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2017English

Levosimendan in Patients With Acute Cardiogenic Shock, Not Responders to Conventional Therapy

Critical Care
Critical CareIntensive Care Medicine
2007English

Candida Bloodstream Infection Under Veno-Arterial ECMO Therapy

Critical Care
Critical CareIntensive Care Medicine
2019English

De-Escalation of Support With Veno-Arterial Extracorporeal Membrane Oxygenation and Impella for Cardiogenic Shock: Reply

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients

Journal of Clinical Medicine
2020English

Haemodynamic Efficacy of Microaxial Left Ventricular Assist Device in Cardiogenic Shock: A Systematic Review and Meta-Analysis

Netherlands Heart Journal
Cardiovascular MedicineCardiology
2019English

Correction To: Exclusive Percutaneous Peripheral Veno-Arterial ECMO With Distal Reperfusion of Homolateral Limb

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2018English

Short-Term Mechanical Support and Pharmacotherapy, a New Strategy in Cardiogenic Shock?

Netherlands Heart Journal
Cardiovascular MedicineCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy